More than 30 years experience in the healthcare industry with several international assignments at Baxter : Mexico General Manager , Belgium V.P Controller Europe, Miami V.P Controller-International. Several key positions in EU such President Shared Services Europe, President G5 Markets and President ECEMEA ( Eastern Europe, Africa, and the Middle East). At Baxter Vicente has led: the integration of Baxter-Immuno, the spin-off of Edwards Life Science, the acquisition and integration of Bieffe Medical, initiated Russian JV, managed the JV in Poland, the acquisition of local IV manufacturers, the expansion of the Turkey JV, the establishment of the JV in Saudi Arabia, establishment of the JV in South Africa, managed Baxter license agreements in the Middle East and North Africa. Managing Partner at Thinking Global. Education : Degree in Law by University of Deusto ,Bilbao, Degree in Economics by I.C.A.D.E Madrid, M.B.A by I.E.S.E. Business School Barcelona.
Co-founder of Thinkeen Europe, Denis has more than 25 years experience in Vaccines and Specialty Pharma in France, Germany, Italy and Austria. He then held commercial and general management positions with Sanofi Pasteur MSD as Commercial Director in Italy , with Baxter first as Vice President Sales & Marketing Vaccines Europe based in Vienna , Austria, then as Business Unit Director for Bioscience division in France . He was recently Business Unit Director for Merck Serono’s Neurology division in France. He also has held different positions in Industry associations: member of the Board of EVM (European Vaccines Manufacturers), and President of PPTA – Plasma Proteins Manufacturers . Denis hold a Master from National Institute of Applied Sciences (INSA) Toulouse, France, and holds a Master in Agro-Food Business from ESSEC Business School, Cergy, France.
Dr. Xavier Champavere Ph.D.
Co-founder of Thinkeen Europe, Xavier has gathered over 30 years of experience in the lifescience sector including 15 years in the vaccine industry with Aventis Pasteur MSD and general management positions in France and Argentina, UK, Italy & Greece. Today he is also Non-Executive Director to the board of Moleac Pte (biopharmaceutical ). In 2012 Xavier joined Cellectis Bioresearch (global leader in Gene Editing & Cell line Engineering) as deputy CEO. Previously he held key leadership positions in the service industry (CRM, CSO,CRO) for the pharmaceutical companies (Cegedim CRM & Data collection, Cider Santé and Arvem CS). Other positions: BUD for France, Belgium & Luxembourg at Serono Biotech, Managing Director Italy & France at Sanofi Pasteur MSD and Director Commercial Development UK & Ireland. Xavier holds a Ph.D. in Biochemical Engineering at University of Compiègne and is an alumnus of INSEAD, ESCP and Henley Management College executive programs.
Peter’s experiences encompass primarily Healthcare and Life Sciences, with some of the top company brands across a variety of industries with experience in general management, marketing, sales, business development and commercial training, with more than 20 years of B2B achievements. Recent experiences: General Manager at Lab Corp with full P&L, responsibility, Head of Sales Operations and Customer Experience at OrthoSensor, a MedTech start-up, Principal at Korn/Ferry for the Healthcare practice in the Miami office, Director of Sales and Marketing Effectiveness at Baxter Latin America and Canada Region, General Manager within one of Cardinal Health’s B2B businesses for over 5 years and various Commercial positions at Abbott Laboratories, across multi Divisions. Peter has a B.S. in Medical Sciences at the University of Illinois at Chicago and an executive MBA at the Lake Forest Graduate School of Management.
Severine holds 15+ years experience as senior medical and marketing executive in multinational companies and start-ups specializing in rare diseases and biotechnologies. Severine started her carrier at Serono and launched Rebif® as Medical Director
for 5 years. Her proven managerial expertises are centered on: market access,
customer engagement, design and establishment of new, higher medical standard and the development of successful, patient centric, value proposition. For instances she
managed and implemented the successful launch of Elocta (Hemophilia) at SOBI in France. Severine holds an MD degree from the University Paris XI and she has succesfully graduated from the INSEAD TGM program.
Christian is an experienced and dually-trained and licensed counsel with a 20+ year solid track record of advising clients and senior management on critical legal and compliance issues, and strategic and operational matters bot domestically and also internationally. Christian’s vast experience includes partnership and senior leadership positions at top global law firms such as Baker & McKenzie and Arnold & Porter, and in billion-dollar healthcare companies such as Baxter International, Olympus Corporation and OPKO Health. Christian holds an LL.B from Universidad Católica Andrés Bello in Caracas, a J.D, cum laude, from the University of Miami School of Law and an LL.M from Georgetown University Law Center. He is also admitted to the practice of law in the District of Columbia, Florida and Venezuela.
Luigi founded Thinkeen® in early 2013. In the previous twenty years, Luigi has worked in several international assignments with both commercial and general management responsibilities in the biotechnology and medical devices industry across multiple global corporations. These included VP Northern Europe for CR Bard, VP-GM Emerging Markets of Latin America at Baxter Health Care, Area GM for Poland & Russian Federation at Baxter Health Care . Luigi holds a MS in Engineering from the University of Bologna (Italy) and an MBA from the University of Kansas. Today Luigi is Managing Partner at Thinkeen® Global Consulting specialising in global commercial strategy for the Life Science industry.
Carlos is a US CPA with over 24 years of experience in Finance in healthcare, telecom projects, M&A and consumer electronics. Carlos was recently CFO of Andean Tower Partners - Digital Bridge (Telecommunication infrastructure) for the last 2 years. Previously, Carlos was Regional Sales Controller for Apple Latin America for over six years. Prior to that, Carlos had a 16-year career at Baxter Healthcare starting as Argentina country controller, Bioscience and Renal business unit Controller, Renal Therapy Services M&A and finalizing as Emerging Market Finance Director. Carlos received his BA in Accounting from UNRC in Argentina, an MBA and MIM from University of St Thomas - MN, a Global Finance Executive program at Carlson School of Management, and a Commercial Banking Certificate at Florida International University.